Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Fast Money Traders Share Their Biotech Picks
–… Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? (GuruFocus)
Related CELG
Celgene To See Major Upside In 2017, Says Canaccord
Celgene's Phase 3 Study Of REMARC Likely To Be Successful, Says Jefferies
Celgene Unlocking Value Through Industry Dominance (Seeking Alpha)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!